Thermoplastics Selection for Medical Devices
Thursday, June 11, 2020
Sponsored by M. Holland Company
Please join us at 2pm(est)/ 1pm(cst)
Choosing the right material for a medical device is a complex process with significant implications on functionality, durability, cost, and supply chain security. Now, with more manufacturers pivoting to the production of medical and emergency equipment to aid in the fight against COVID-19, it is more critical than ever to understand the complexities and regulatory guidelines that impact medical-grade material selection.
Join Josh Blackmore, Global Healthcare Manager, of M. Holland Company for a webinar on June 11th, as he provides guidance on material selection, regulatory considerations and how to minimize supply chain risk. He will outline a process that empowers medical device engineers to consider a greater variety of medical-grade resins, which can positively affect innovations in device design and improve costs and resin availability.
Josh Blackmore serves as global healthcare manager for M. Holland. In this role, he focuses on expanding targeted products and services and creating a seamless purchasing experience for healthcare clients. He coordinates with sales and suppliers to strengthen M. Holland’s medical materials portfolio. He ensures that the resources necessary to determine how medical grade plastics meet device needs and comply with regulatory testing are in place. Josh is also a member of the Additive Manufacturing Council at M. Holland, providing insight on medical grade materials as related to the 3D printing market.
Josh came to M. Holland from RTP Company (RTP) where he was the global healthcare manager for more than 13 years. He was responsible for creating and implementing a strategic global plan to establish RTP as a leader in the medical industry, developing and coaching the company’s medical sales team and managing the global project pipeline. Prior to RTP, he held positions at GE and The Dow Chemical Company.
He earned a Bachelor of Science degree in medical technology from Michigan State University and a Master of Business Administration from the University of Notre Dame’s Mendoza College of Business